Dapagliflozin propanediol is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus by helping to lower blood glucose levels. This category provides… Read more
Dapagliflozin propanediol is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus by helping to lower blood glucose levels. This category provides access to high-quality reference standards essential for pharmaceutical laboratories conducting rigorous analytical testing and quality control. Alongside the active pharmaceutical ingredient, researchers require access to pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds to ensure accurate impurity profiling and method validation. By utilizing these characterized reference materials, laboratories can support regulatory compliance and ensure the precision of analytical methods used during drug development and batch release testing. The availability of these distinct standards allows for the identification and quantification of related substances, supporting the comprehensive assessment of drug substance and drug product stability.